{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T20:26:19Z","timestamp":1775507179764,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"DOI":"10.1007\/s10792-025-03658-4","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T05:01:09Z","timestamp":1752555669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of botulinum toxin as a non-surgical option for upper eyelid retraction in active thyroid-associated ophthalmopathy: a prospective interventional study"],"prefix":"10.1007","volume":"45","author":[{"given":"Sonali Vinay","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok","family":"Sati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha V.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"3658_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","volume":"121","author":"GB Bartley","year":"1996","unstructured":"Bartley GB, Fatourechi V, Kadrmas EF, Jacobsen SJ, Ilstrup DM, Garrity JA et al (1996) Clinical features of Graves\u2019 ophthalmopathy in an incidence cohort. Am J Ophthalmol 121:284\u2013290","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3658_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jaapos.2010.07.005","volume":"14","author":"LR Dagi","year":"2010","unstructured":"Dagi LR, Elliott AT, Roper-Hall G, Cruz OA (2010) Thyroid eye disease: honing your skills to improve outcomes. J Aapos 14(5):425\u2013431","journal-title":"J Aapos"},{"issue":"2","key":"3658_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41433-018-0302-1","volume":"33","author":"P Meyer","year":"2019","unstructured":"Meyer P, Das T, Ghadri N, Murthy R, Theodoropoulou S (2019) Clinical pathophysiology of thyroid eye disease: the Cone Model. Eye (Lond) 33(2):244\u2013253","journal-title":"Eye (Lond)"},{"issue":"16","key":"3658_CR4","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Hegedus L (2016) Graves\u2019s disease. N Eng J Med 375(16):1552\u20131565","journal-title":"N Eng J Med"},{"issue":"8","key":"3658_CR5","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","volume":"37","author":"L Bartalena","year":"2014","unstructured":"Bartalena L, Fatourechi V (2014) Extrathyroidal manifestations of Gravs\u2019s disease: a 2014 update. J Endocrinol Invest 37(8):691\u2013700","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"3658_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2169\/internalmedicine.53.1518","volume":"53","author":"Y Hiromatsu","year":"2014","unstructured":"Hiromatsu Y et al (2014) Graves\u2019 ophthalmology: epidemiology and natural history. Intern Med 53(5):353\u2013360","journal-title":"Intern Med"},{"issue":"3","key":"3658_CR7","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1167\/iovs.14-14002","volume":"55","author":"Y Wang","year":"2014","unstructured":"Wang Y, Smith TJ (2014) Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci 55(3):1735\u20131748","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"3658_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/WNO.0000000000000132","volume":"34","author":"SJ Shan","year":"2014","unstructured":"Shan SJ, Douglas RS (2014) The pathophysiology of thyroid eye disease. J Neuroophthalmol 34(2):177\u2013185","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"3658_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ajo.2006.02.047","volume":"142","author":"JA Garrity","year":"2006","unstructured":"Garrity JA, Bahn RS (2006) Pathogenesis of graves ophthalmology: implications for prediction, prevention, and treatment. Am J Ophthalmol 142(1):147\u2013153","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"3658_CR10","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF03345280","volume":"27","author":"L Bartalena","year":"2004","unstructured":"Bartalena L, Wiersinga WM, Pinchera A (2004) Graves\u2019 ophthalmopathy: state of the art and perspectives. J Endocrinol Invest 27(3):295\u2013301","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"3658_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.survophthal.2012.02.007","volume":"58","author":"AA Cruz","year":"2013","unstructured":"Cruz AA et al (2013) Graves upper eyelid retraction. Surv Ophthalmol 58(1):63\u201376","journal-title":"Surv Ophthalmol"},{"key":"3658_CR12","first-page":"224","volume":"12","author":"AB Scott","year":"1973","unstructured":"Scott AB, Rosenbaum A, Collins CC (1973) Pharmacologic weakening of extraocular muscles. Invest Ophthalmol 12:224\u2013227","journal-title":"Invest Ophthalmol"},{"key":"3658_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1530\/eje.1.02230","volume":"155","author":"WM Wiersinga","year":"2006","unstructured":"Wiersinga WM, Kahaly GJ, Kahaly GJ, Kahaly GJ, Mourits MP, Baldeschi L et al (2006) Clinical assessment of patients with Graves\u2019 orbitopathy: the European group on Graves\u2019 orbitopathy recommendations to generalists, specialists and clinical researchers. Eur J Endocrinol 155:387\u2013389","journal-title":"Eur J Endocrinol"},{"key":"3658_CR14","first-page":"258","volume":"13","author":"R Ebner","year":"1993","unstructured":"Ebner R (1993) Botulinum toxin type A in upper lid retraction of Graves\u2019 ophthalmopathy. J Clin Neuro-ophthalmol 13:258\u2013261","journal-title":"J Clin Neuro-ophthalmol"},{"key":"3658_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000310837","volume":"211","author":"SB Ozkan","year":"1997","unstructured":"Ozkan SB, Can D, Soylev MF, Arsan AK, Duman S (1997) Chemodenervation in treatment of upper eyelid retraction. Ophthalmologica 211:387\u2013390","journal-title":"Ophthalmologica"},{"key":"3658_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/eye.2008.165","volume":"23","author":"PG Costa","year":"2009","unstructured":"Costa PG, Saraiva FP, Pereira IC, Monteiro MLR, Matayoshi S (2009) Comparative study of Botox injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage. Eye (Lond) 23:767\u2013773","journal-title":"Eye (Lond)"},{"issue":"5","key":"3658_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/01676830.2020.1814351","volume":"40","author":"G Ozturk Karabulut","year":"2021","unstructured":"Ozturk Karabulut G, Fazil K, Saracoglu Yilmaz B, Ozturker C, G\u00fcnayd\u0131n ZK, Taskapili M, Kaynak P (2021) An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results. Orbit 40(5):381\u2013388","journal-title":"Orbit"},{"issue":"6","key":"3658_CR18","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/IOP.0000000000001120","volume":"34","author":"SM Young","year":"2018","unstructured":"Young SM, Kim YD, Lang SS, Woo KI (2018) Transconjunctival triamcinolone injection for upper lid retraction in thyroid eye disease\u2014a new injection method. Ophthalmic Plast Reconstr Surg 34(6):587\u2013593","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"3658_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/eye.1990.74","volume":"4","author":"CJ Lyons","year":"1990","unstructured":"Lyons CJ, Vickers SF, Lee JP (1990) Botulinum toxin therapy in dysthyroid strabismus. Eye 4:538\u2013540","journal-title":"Eye"},{"key":"3658_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3928\/0191-3913-19940901-03","volume":"31","author":"J Lee","year":"1994","unstructured":"Lee J, Harris S, Cohen J et al (1994) Results of a prospective randomized trial of botulinum toxin therapy acute unilateral sixth nerve palsy. J Pediatr Ophthalmol Strabismus 31:283\u2013286","journal-title":"J Pediatr Ophthalmol Strabismus"},{"issue":"5","key":"3658_CR21","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.mjafi.2021.09.007","volume":"79","author":"S Vinay Kumar","year":"2023","unstructured":"Vinay Kumar S, Kumar V, Mishra S, Sati A (2023) Efficacy and safety of injection Botulinum toxin in canalicular obstruction due to trauma. Med J Armed Forces India 79(5):584\u2013589","journal-title":"Med J Armed Forces India"},{"key":"3658_CR22","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1136\/bjo.69.10.718","volume":"69","author":"JS Elston","year":"1985","unstructured":"Elston JS, Lee JP, Hogg PC, Clark P (1985) Treatment of strabismus in adults with botulinum toxin A. Br J Ophthalmol 69:718\u2013724","journal-title":"Br J Ophthalmol"},{"key":"3658_CR23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s40618-021-01663-9","volume":"45","author":"EJ Neag","year":"2022","unstructured":"Neag EJ, Smith TJ (2022) update on thyroid-associated ophthalmopathy. J Endocrinol Invest 45:235\u2013259","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"3658_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/sj.eye.6700690","volume":"18","author":"MJ Shih","year":"2004","unstructured":"Shih MJ, Liao SL, Lu HY (2004) A single transcutaneous injection with Botox for dysthyroid lid retraction. Eye (Lond) 18(5):466\u2013469","journal-title":"Eye (Lond)"},{"key":"3658_CR25","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0161-6420(02)01041-2","volume":"109","author":"JM Uddin","year":"2002","unstructured":"Uddin JM, Davies PD (2002) Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection. Ophthalmology 109:1183\u20131187","journal-title":"Ophthalmology"},{"key":"3658_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1034\/j.1600-0420.2001.790608.x","volume":"79","author":"F Traisk","year":"2001","unstructured":"Traisk F, Tallstedt L (2001) Thyroid associated ophthalmopathy: botulinum toxin A in the treatment of upper eyelid retraction. A pilot study Acta Ophthalmol Scand 79:585\u2013588","journal-title":"A pilot study Acta Ophthalmol Scand"},{"issue":"2","key":"3658_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/01676830903324268","volume":"29","author":"H Salour","year":"2010","unstructured":"Salour H, Bagheri B, Aletaha M, Babsharif B, Kleshadi M, Abrishami M, Bagheri A (2010) Transcutaneous dysport injection for treatment of upper eyelid retraction associated with thyroid eye diseases. Orbit 29(2):114\u2013118","journal-title":"Orbit"},{"issue":"3","key":"3658_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00002341-200405000-00001","volume":"20","author":"KE Morgenstern","year":"2004","unstructured":"Morgenstern KE, Evanchan J, Foster JA, Cahill KV, Burns JA, Holck DE, Perry JD, Wulc AE (2004) Botulinum toxin type a for dysthyroid upper eyelid retraction. Ophthalmic Plast Reconstr Surg 20(3):181\u2013185","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"1","key":"3658_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00417-012-2153-y","volume":"251","author":"SJ Lee","year":"2013","unstructured":"Lee SJ, Rim TH, Jang SY, Kim CY, Shin DY, Lee EJ et al (2013) Treatment of upper eyelid retraction related to thyroid associated ophthalmopathy using subconjunctival triamcinolone injections. Graefes Arch Clin Exp Ophthalmol 251(1):261\u2013270","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"5","key":"3658_CR30","doi-asserted-by":"publisher","first-page":"e485","DOI":"10.1097\/SCS.0000000000009347","volume":"0134","author":"J Yang","year":"2023","unstructured":"Yang J, Hu X, Li Q, Huang RL (2023) Botulinum toxin type a injection for correction of upper eyelid retraction in thyroid-associated ophthalmopathy. J Craniofac Surg 0134(5):e485\u2013e488","journal-title":"J Craniofac Surg"},{"issue":"4","key":"3658_CR31","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jfo.2016.10.016","volume":"40","author":"A Nava Castaneda","year":"2017","unstructured":"Nava Castaneda A, Tovilla Canales JL, Garnica Hayashi L, Velasco Y, Levy A (2017) Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A. J Fr Ophthalmol 40(4):279\u2013284","journal-title":"J Fr Ophthalmol"},{"issue":"1","key":"3658_CR32","doi-asserted-by":"publisher","first-page":"5103","DOI":"10.1038\/s41598-025-89063-4","volume":"15","author":"Z Huang","year":"2025","unstructured":"Huang Z, Xu M, Zhang W, Song X (2025) Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid- associated ophthalmopathy. Sci Rep 15(1):5103","journal-title":"Sci Rep"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03658-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-025-03658-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-025-03658-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T18:03:39Z","timestamp":1766167419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-025-03658-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3658"],"URL":"https:\/\/doi.org\/10.1007\/s10792-025-03658-4","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"18 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee (Command Hospital Eastern Command, Kolkata) and with the 1964 Helsinki Declaration and its amendments or comparable ethical standards. This manuscript did not involve any kind of animal research. All the authors consent to the publication of this manuscript in International Ophthalmology.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"293"}}